Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
CPT: Pharmacometrics & Systems Pharmacology|February 9, 2024
Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseasesFarzaneh Maleki, Elias Clark, Christopher Banfield, et al.
Clinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.
Clinical Pharmacology and Therapeutics|March 26, 2025
Impact of Model-Informed Drug Development on Drug Development Cycle Times and Clinical Trial CostVaishali Sahasrabudhe, Timothy Nicholas, Gianluca Nucci, et al.
Clinical Pharmacology in Drug Development|September 1, 2022
Population Pharmacokinetics of Oral Brepocitinib in Healthy Volunteers and PatientsJim H Hughes, Ruolun Qiu, Christopher Banfield, et al.
Human Reproduction (Oxford, England)|October 19, 2021
Ethical considerations of preconception and prenatal gene modification in the embryo and fetusCitra Nurfarah Zaini Mattar, Markus Klaus Labude, Timothy Nicholas Lee, et al.
British Journal of Clinical Pharmacology|March 28, 2022
Population pharmacokinetic-pharmacodynamic modelling of platelet time-courses following administration of abrocitinibJessica Wojciechowski, Bimal K Malhotra, Xiaoxing Wang, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 20, 2019
Population pharmacokinetics of tofacitinib in patients with psoriatic arthritisRujia Xie, Chenhui Deng, Qiang Wang, et al.
Clinical Pharmacokinetics|January 21, 2022
Population Pharmacokinetics of Abrocitinib in Healthy Individuals and Patients with Psoriasis or Atopic DermatitisJessica Wojciechowski, Bimal K Malhotra, Xiaoxing Wang, et al.
Clinical Pharmacology and Therapeutics|September 14, 2022
Population PK and PD Analysis of Domagrozumab in Pediatric Patients with Duchenne Muscular DystrophyJessica Wojciechowski, Vivek S Purohit, Lutz O Harnisch, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 1, 2024
Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritisCheng Chang, Camille Vong, Xiaoxing Wang, et al.
Pageof 6